UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Modulation of lncRNA links endothelial glycocalyx to vascular dysfunction of tyrosine kinase inhibitor Journal article
Nukala, Sarath Babu, Jousma, Jordan, Yan, Gege, Han, Zhenbo, Kwon, Youjeong, Cho, Yoonje, Liu, Chuyu, Gagnon, Keith, Pinho, Sandra, Rehman, Jalees, Shao, Ning Yi, Ong, Sang Bing, Lee, Won Hee, Ong, Sang Ging. Modulation of lncRNA links endothelial glycocalyx to vascular dysfunction of tyrosine kinase inhibitor[J]. Cardiovascular research, 2023, 119(10), 1997-2013.
Authors:  Nukala, Sarath Babu;  Jousma, Jordan;  Yan, Gege;  Han, Zhenbo;  Kwon, Youjeong; et al.
Favorite | TC[WOS]:6 TC[Scopus]:4  IF:10.2/10.6 | Submit date:2023/09/04
Cardio-oncology  Glycocalyx  Ipscs  Lncrnas  Vascular Toxicity  
VEGFR tyrosine kinase inhibitor II (VRI) induced vascular insufficiency in zebrafish as a model for studying vascular toxicity and vascular preservation Journal article
Shang Li, Yuan Ye Dang, Ginny Oi Lam Che, Yiu Wa Kwan, Shun Wan Chan, George Pak Heng Leung, Simon Ming Yuen Lee, Maggie Pui Man Hoi. VEGFR tyrosine kinase inhibitor II (VRI) induced vascular insufficiency in zebrafish as a model for studying vascular toxicity and vascular preservation[J]. Toxicology and Applied Pharmacology, 2014, 280(3), 408-420.
Authors:  Shang Li;  Yuan Ye Dang;  Ginny Oi Lam Che;  Yiu Wa Kwan;  Shun Wan Chan; et al.
Favorite | TC[WOS]:37 TC[Scopus]:37  IF:3.3/3.6 | Submit date:2018/11/06
Cardiovascular Protective Agents  Cardiovascular Toxicity  Vascular Insufficiency  Zebrafish Model